Blog - Page 3 of 5587 - QualityStocks

FridayMar 20, 2026 11:26 am

QualityStocksNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) CEO To Present At Emerging Growth Conference

Perpetuals.com (NASDAQ: PDC) announced that CEO Patrick Gruhn will present and host a live question-and-answer session at the Emerging Growth Conference on April 1, 2026, at 12:35 p.m. ET, where he is expected to discuss the company AI-powered financial services platform and engage with investors. To view the full press release, visit https://ibn.fm/oLVBV About Perpetuals.com Ltd. Perpetuals.com Ltd. (NASDAQ: PDC) is a financial technology company combining blockchain infrastructure and artificial intelligence to transform digital asset trading. The company develops and operates Kronos X, a proprietary multi-asset exchange platform and blockchain-based settlement solution fully compliant with European regulations, including MiFID II, MiCA, DORA, and EMIR. The…

FridayMar 20, 2026 11:15 am

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs. The UK Medicines and Healthcare Products Regulatory Agency granted Promising Innovative Medicine designation to Soligenix’s SGX945 (dusquetide) for the treatment of Behçet’s disease. The recent designation in the United Kingdom builds on other regulatory recognitions previously granted to dusquetide. Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and…

FridayMar 20, 2026 10:50 am

QualityStocksNewsBreaks – Pelican Acquisition Corp. (NASDAQ: PELI) Approves Business Combination With Greenland Exploration And Pelican Holdco

Pelican Acquisition (NASDAQ: PELI) announced that shareholders approved its proposed business combination with Pelican Holdco Inc., Greenland Exploration Limited and March GL Company at an extraordinary general meeting held March 19, 2026, with closing of the transaction expected on or about March 24, 2026. The deal is intended to form a publicly traded energy company focused on advancing global energy security through the responsible development of Greenland natural resources. To view the full press release, visit https://ibn.fm/sa5y4 About Greenland Exploration Limited Greenland Exploration Limited is a Texas-based entity focused on developing strategic positions in North American energy assets. Through its…

FridayMar 20, 2026 10:30 am

Safe Pro Group Inc. (NASDAQ: SPAI) Delivers Critical Security and Defense Solutions to Governments and Organizations

Safe Pro Group delivers AI, drone-based services, and ballistic protective gear, to customers in the defense, law enforcement, humanitarian, and homeland security industries. At the heart of the company’s mission is a computer vision technology used to rapidly detect and identify small explosive objects such as landmines in drone footage, enabling safer and more efficient field operations in both conflict and post-conflict zones. The company maintains close communication with government and commercial clients, recently signing and completing key contracts. Safe Pro Group (NASDAQ: SPAI) is a technology company delivering advanced security and defense solutions to customers in government and industry,…

FridayMar 20, 2026 10:00 am

QualityStocksNewsBreaks – Black Hawk Acquisition Corporation (Nasdaq: BKHA) SPAC Target Vesicor Therapeutics Names Michael Tolentino CEO

Black Hawk Acquisition (Nasdaq: BKHA, BKHAU, BKHAR) announced that its proposed de-SPAC acquisition target, Vesicor Therapeutics Inc., has appointed Michael Tolentino, M.D., as chief executive officer effective March 17, 2026, succeeding founder Luo Feng, Ph.D., who will transition to chief scientific officer as the company advances its p53-based cancer therapeutic platform and prepares for IND-enabling studies and a planned FDA submission. Dr. Tolentino brings more than 20 years of biotechnology leadership experience spanning drug discovery, clinical development and company building, including roles in the development of Avastin and leadership positions at multiple biotech firms, and is expected to support execution of Vesicor growth strategy and progression toward…

FridayMar 20, 2026 9:45 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within this evolving scientific landscape, LIXTE Biotechnology is pursuing a strategy designed to improve the performance of existing cancer treatments. Inhibiting PP2A with LB-100 may increase tumor sensitivity to chemotherapy and radiation while also enhancing immune system activity against cancer cells. Experts working across oncology are exploring how different treatment approaches can work together to improve outcomes for cancer patients. One area drawing significant attention involves combining immunotherapy with chemotherapy to help the immune system better recognize and attack tumors. LIXTE Biotechnology Holdings (NASDAQ: LIXT) is…

FridayMar 20, 2026 9:40 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Strategic Cooperation Agreement With BonV Aero To Expand Counter-UAS Presence In India

ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV Aero to market its portfolio of counter-UAS solutions, led by the DefendAir system, a mobile, net-based interception platform designed for rapid deployment against hostile drones, while also enabling future configurations and integrations. The companies have already conducted a live demonstration of the portable DefendAir launcher for a key security entity in India, validating its real-world effectiveness and positioning ParaZero to expand its presence in a strategically important market as it explores additional collaboration opportunities across counter-drone applications. To view the full press release, visit https://ibn.fm/maAxq…

FridayMar 20, 2026 9:00 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Strengthens Board of Directors, Prepares Live Webinar on Gold Operation in Abitibi

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur Minerals is a Canada-headquartered near-term gold producer, leveraging its mine and mill assets in the prolific Abitibi Gold Belt, Quebec, to restart gold production in Q22026 LaFleur’s top management will conduct a live webinar on Tuesday, March 24, to discuss the company’s recent developments, the pending resumption of gold production within the next few months, and LaFleur’s long-term vision of consolidation and scalability The company’s Swanson Gold Project and Beacon Gold Mill assets have the potential to produce significant economic returns under a…

ThursdayMar 19, 2026 11:16 am

QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) Highlights New Craigmont Thesis Supporting Porphyry Potential

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising. Nicola Mining (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) reported results from a University of British Columbia M.Sc. thesis on its New Craigmont copper project, which redefines the historical Craigmont deposit as a porphyry-linked skarn system and identifies geochemical and alteration indicators supporting the presence of a nearby porphyry center, reinforcing the company’s exploration model and narrowing target areas to West Craigmont and zones east of the historical mine as it advances toward its 2026 exploration program. To view the full press release, visit https://ibn.fm/qLorA About Nicola Mining Nicola Mining Inc. is…

ThursdayMar 19, 2026 11:15 am

Renewal Fuels Inc. (RNWF) Discusses Ambitious Fusion Reactor Plan, Business Model and Strategy, on Stock2Me Podcast

The company aims to deliver a 100-megawatt fusion reactor in 2026, with an earlier 5-MW pre-production system currently in development. Initial deployments are expected to focus on behind-the-meter power generation for data centers and industrial facilities. Management intends to sell electricity under long-term contracts priced around $0.0625 per kilowatt-hour, competitive with some renewable power sources. The company’s plan targets 1 gigawatt of delivered capacity by 2028, followed by rapid expansion if early deployments prove successful. Management is preparing a Form 10 registration and potential uplisting, initially to the OTCQB and eventually to a major exchange. Fusion energy has long been…

Site Search

Company Search